Glycemic relapse in type 2 diabetes

Endocrine Practice

Volumn 12, Issue 2, 2006, Pages 145-151

  Graber, Alan L ^a   Shintani, Ayumi K ^b   Wolff, Kathleen ^c   Brown, Anne ^c   Elasy, Tom A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RECURRENT DISEASE; TIME; WEIGHT REDUCTION;

ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; WEIGHT LOSS;

EID: 33745365115     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.2.145     Document Type: Article

References (25)

1. Merriam-Webster's Collegiate Dictionary. 11th ed. Springfield, MA: Merriam-Webster, Incorporated, 2004: 1050.
2. Marlatt GA, Gordon JR, eds. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, NY: Guilford Press, 1985.
3. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [erratum in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
6. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103-117.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2004;27(Suppl 1):S15-S35.
8. Brown AW, Wolff KL, Elasy TA, Graber AL. The role of advanced practice nurses in a shared care diabetes practice model. Diabetes Educ. 2001;27:492-496, 498-500, 502.
9. Graber AL, Elasy TA, Quinn D, Wolff K, Brown A. Improving glycemic control in adults with diabetes mellitus: shared responsibility in primary care practices. South Med J. 2002;95:684-690.
10. Quinn DC, Graber AL, Elasy TA, Thomas J, Wolff K, Brown A. Overcoming turf battles: developing a pragmatic, collaborative model to improve glycemic control in patients with diabetes. Jt Comm J Qual Improv. 2001;27: 255-264.
11. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131:281-303.
12. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment: results of a randomized controlled trial. Diabetes Care. 1995;18:943-949.
13. Harrell FE. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer-Verlag, 2001.
14. Elasy TA, Graber AL, Wolff K, Brown A, Shintani A. Glycemic relapse after an intensive outpatient intervention for type 2 diabetes [letter]. Diabetes Care. 2003;26:1645-1646.
15. Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy [erratum in N Engl J Med. 2000;342:1376]. N Engl J Med. 2000;342:381-389.
16. Lawson ML, Frank MR, Fry MK, Perlman K, Sochett EB, Daneman D. Intensive diabetes management in adolescents with type 1 diabetes: the importance of intensive follow-up. J Pediatr Endocrinol Metab. 2000;13:79-84.
17. Couper JJ, Taylor J, Fotheringham MJ, Sawyer M. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care. 1999;22:1933-1937.
18. Rosilio M, Cotton JB, Wieliczko MC, et al (French Pediatric Diabetes Group). Factors associated with glycemic control: a cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care. 1998;21:1146-1153.
19. Spiess K, Sachs G, Moser G, Pietschmann P, Schernthaner G, Prager R. Psychological moderator variables and metabolic control in recent onset type 1 diabetic patients - a two year longitudinal study. J Psychosom Res. 1994;38:249-258.
20. Bott U, Jorgens V, Grusser M, Bender R, Mulhauser I, Berger M. Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med. 1994;11:362-371.
21. Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000;23:273-277.
22. Trief PM, Grand W, Elbert K, Weinstock RS. Family environment, glycemic control, and the psychosocial adaptation of adults with diabetes. Diabetes Care. 1998;21:241-245.
23. Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med. 1998;15:290-296.
24. Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care. 2005;28:995-1000.
25. Cook CB, Lyles RH, El-Kebbi I, et al. The potentially poor response to outpatient diabetes care in urban African-Americans. Diabetes Care. 2001;24:209-215.